SIK2 and ovarian carcinoma: SIK2 activity is associated with the autophosphorylation level of S358, a key residue regulating SIK2 protein stability (33), and MRIA9 significantly reduced SIK2 S358 autophosphorylation, SIK2 activity, and ovarian cancer cell metastasis.